Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Molecular epidemiology of African sleeping sickness

Domain:

healthcare

Record type:

paper
Creator:
G. A.
Publisher:
Cam
Host:
SUMMARY Human sleeping sickness in Africa, caused by Trypanosoma brucei spp. raises a number of questions. Despite the widespread distribution of the tsetse vectors and animal trypanosomiasis, human disease is only found in discrete foci which periodically give rise to epidemics followed by periods of endemicity A key to unravelling this puzzle is a detailed knowledge of the aetiological agents responsible for different patterns of disease – knowledge that is difficult to achieve using traditional microscopy. The science of molecular epidemiology has developed a range of tools which have enabled us to accurately identify taxonomic groups at all levels (species, subspecies, populations, strains and isolates). Using these tools, we can now investigate the genetic interactions within and between populations of Trypanosoma brucei and gain an understanding of the distinction between human- and nonhuman-infective subspecies. In this review, we discuss the development of these tools, their advantages and disadvantages and describe how they have been used to understand parasite genetic diversity, the origin of epidemics, the role of reservoir hosts and the population structure. Using the specific case of T.b. rhodesiense in Uganda, we illustrate how molecular epidemiology has enabled us to construct a more detailed understanding of the origins, generation and dynamics of sleeping sickness epidemics.

Visit

doi.org

Licenses

https://www.cambridge.org/core/terms

Similar

Molecular epidemiology of the African horse sickness virus S10 geneThe Molecular Dynamics of <i>Trypanosoma brucei</i> UDP‐Galactose 4′‐Epimerase: A Drug Target for African Sleeping SicknessInvestigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sicknessHistory of Sleeping Sickness in East AfricaNovel lead compounds in pre-clinical development against African sleeping sicknessCell Cycle Inhibition To Treat Sleeping Sickness

Molecular epidemiology of the African horse sickness virus S10 gene

Between 2004 and 2006, 145 African horse sickness viruses (AHSV) were isolated from blood and organ

The Molecular Dynamics of <i>Trypanosoma brucei</i> UDP‐Galactose 4′‐Epimerase: A Drug Target for African Sleeping Sickness

During the past century, several epidemics of human African trypanosomiasis, a deadly disease caused

Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness

African sleeping sickness is a potentially fatal neglected disease affecting sub-Saharan Africa.

History of Sleeping Sickness in East Africa

SUMMARY The history of human sleeping sickness in East Africa is characterized by the appearance of

Novel lead compounds in pre-clinical development against African sleeping sickness

This article reviews the recent progress in drug development against the African sleeping sickness.

Cell Cycle Inhibition To Treat Sleeping Sickness

ABSTRACT African trypanosomiasis is caused by infection with the protozoan parasite Trypanosoma bru